Statistics from Altmetric.com
Do central venous catheters treated with anti-infective agents (AI-CVCs) prevent catheter-related bloodstream infections (CRBSIs)?
Included studies compared AI-CVCs with standard CVCs or a different AI-CVC for preventing CRBSIs in patients requiring a CVC. Primary outcome was diagnosis of a CRBSI (the same micro-organism identified in both the catheter and the bloodstream).
Medline, EMBASE/Excerpta Medica, SCI/Web of Science, SCI/ISI Proceedings, and Cochrane Library (to Sep 2007) were searched for randomised controlled trials (RCTs). Trials involving AI-CVCs that required in-house preparation were excluded. 38 RCTs (n = ∼9000 patients) met the selection criteria. Methodological quality of the trials was generally poor: 10 RCTs reported …
Source of funding: Health Technology Assessment Programme.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.